Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Completed1
Active, not recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed125%
active_not_recruiting125%
unknown125%
recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Conversion to SADI-S, RYGB or OAGB After Failed Sleeve

NCT05608772
active_not_recruiting

Outcome After Revisions of Infected Knee Arthroplasties

NCT04427943
completed

Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection

NCT05804058
unknownnot_applicable

PRO-DIAG: Improved Diagnosis of Prosthetic Joint Infections

NCT03444571

Clinical Trials (4)

Showing 4 of 4 trials
NCT05608772Not Applicable

Conversion to SADI-S, RYGB or OAGB After Failed Sleeve

Recruiting
NCT04427943

Outcome After Revisions of Infected Knee Arthroplasties

Active Not Recruiting
NCT05804058

Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection

Completed
NCT03444571Not Applicable

PRO-DIAG: Improved Diagnosis of Prosthetic Joint Infections

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4